RTTNews | Sep 21, 2020 08:16AM EDT

08:15 Monday, September 21, 2020 (RTTNews.com) - Retrophin Says First 280 Patients Enrolled In Pivotal Phase 3 PROTECT Study On Sparsentan

For comments and feedback: contact editorial@rttnews.com

https://www.rttnews.comCopyright(c) 2020 RTTNews.com All Rights Reserved